Experimental Oncology

About the Journal

Current Issue

Vol. 46 No. 3 (2024): Experimental Oncology

Published: 19.12.2024

Reviews

EVOLUTION OF METFORMIN IN BREAST CANCER THERAPY IN LAST TWO DECADES: A REVIEW

R. SARATHI, S. SARUMATHY, V.M. DURAI MAVALAVAN

185-191
- PDF
DOI: https://doi.org/10.15407/exp-oncology.2024.03.185
ROLE OF RIBONUCLEASES IN THE REGULATION OF IMMUNE RESPONSE

V. SHLYAKHOVENKO, O. SAMOYLENKO, A. VERBINENKO, I. GANUSEVICH

192-201
- PDF
DOI: https://doi.org/10.15407/exp-oncology.2024.03.192

Original contributions

EXPRESSION OF IMMUNOGLOBULIN LIGHT CHAIN GENES IN STEREOTYPED CASES FROM UKRAINIAN COHORT OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

I. ABRAMENKO, N. BILOUS, Z. MARTINA, I. DYAGIL, A. CHUMAK

202-208
- PDF
DOI: https://doi.org/10.15407/exp-oncology.2024.03.202
OSTEOPONTIN-REGULATED CHANGES IN THE MAST CELL POPULATION ASSOCIATED WITH BREAST CANCER

О. MUSHII, А. PAVLOVA, V. BAZAS, T. ZADVORNYI, N. LUKIANOVA

209-220
- PDF
DOI: https://doi.org/10.15407/exp-oncology.2024.03.209
IDENTIFICATION OF CLINICALLY RELEVANT GENE VARIANTS IN COLON ADENOCARCINOMA SAMPLES OF UKRAINIAN PATIENTS USING A COMPREHENSIVE CANCER PANEL: A PILOT STUDY

G. GERASHCHENKO, R. GULKOVSKYI, N. MELNICHUK, N. HRYSHCHENKO, T. MARCHYSHAK, O. MANKOVSKA, A. BEZVERKHIY, I. KOTUZA, L. ROSHA, A. KOTUZA, Z. TKACHUK, V. KASHUBA, M. TUKALO

221-227
- PDF
DOI: https://doi.org/10.15407/exp-oncology.2024.03.221
THE INFLUENCE OF BIFIDOBACTERIUM ANIMALIS AND LECTIN OF B. SUBTILIS IMV B-7724 ON THE ANTITUMOR IMMUNE RESPONSE OF MICE WITH EHRLICH ADENOCARCINOMA

N. FEDOSOVA, N. CHEREMSHENKO, S. GOGOL, N. BEZDIENIEZHNYKH, V. TIKHONOV, I. VOYEYKOVA, V. KONOVALENKO, V. CHEKHUN

228-236
- PDF
DOI: https://doi.org/10.15407/exp-oncology.2024.03.228
EFFECT OF ADHESIVE LLC CELL PRETREATMENT BY OXAMATE ON THE SURVIVAL INDEXES AFTER TRANSITION TO DE-ADHESIVE GROWTH

Yu. STEPANOV, D. KOLESNIK, Yu. YAKSHIBAEVA, G. SOLYANIK

237-243
- PDF
DOI: https://doi.org/10.15407/exp-oncology.2024.03.237
SIGNIFICANCE OF miRNA-185-5P AND miRNA-424-5P AS PROGNOSTIC MARKERS IN PROGRESSION OF EARLY-STAGE ENDOMETRIAL CANCER

N.P. IURCHENKO, N.M. GLUSHCHENKO, S.V. NESPRYADKO, L.G. BUCHYNSKA

244-252
- PDF
DOI: https://doi.org/10.15407/exp-oncology.2024.03.244
INFLUENCE OF CONFORMAL RADIOTHERAPY IN COMBINATION WITH RADIOMODIFIERS ON THE CONTENT OF VEGF, COX-2, AND PGE-2 IN BLOOD SERUM OF PATIENTS WITH HEAD AND NECK SQUAMOUS CELL CARCINOMA

N. MITRYAYEVA, L. GREBINYK, S. ARTIUKH, N. BILOZOR, V. STARENKIY

253-259
- PDF
DOI: https://doi.org/10.15407/exp-oncology.2024.03.253
FACTORS AFFECTING COVID-19 OUTCOMES IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

A.M. RUDZITE, D. AUZINA, S. LEJNIECE

260-267
- PDF
DOI: https://doi.org/10.15407/exp-oncology.2024.03.260

Methods and techniques

PROSTATE CANCER DIAGNOSTICS MODELING USING THE INFRARED IMAGING METHOD

B. PARTSVANIA, T. SULABERIDZE, A. KHUSKIVADZE, S. ABAZADZE

268-272
- PDF
DOI: https://doi.org/10.15407/exp-oncology.2024.03.268

Case report

AGGRESSIVE RHABDOID TUMOR IN THE RIGHT LUNG: A CASE REPORT

O. DYADYK, C. SHATROVA, V. ILCHENKO, L. ROSHA, V. ZARITSKA, I. IRKIN, Yu. BEKETOVA, P. SNISAREVSKYI

273-277
- PDF
DOI: https://doi.org/10.15407/exp-oncology.2024.03.273

View All Issues